Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Ross C Donehower

Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct

scientific article published on 02 February 2007

Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum

scientific article

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital

scientific article published on July 2008

Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study

scientific article

Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma

scientific article

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients

scientific article

Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer

scientific article published on 21 June 2017

Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.

scientific article

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

scientific article

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

scientific article

Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer

scientific article published on December 6, 2010

Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.

scientific article

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

scientific article

Phase II study of erlotinib in patients with advanced biliary cancer

scientific article